Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
I. Enache, G. Noel, M. Oswald-Mammosser, M. Y. Jeung, E. Urban-Kraemer, C. Pistea, E. Quoix, A. Charloux (Strasbourg, France). Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients?. Eur Respir J 2011; 38: Suppl. 55, 2776

Member's Comments

No comment yet.

Related content which might interest you: Increased levels of fractional exhaled nitric oxide after chemotherapy for lung cancer. Ongoing study Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Exhaled nitric oxide (eNO) and lung transplantation (LTx): impact of the native lung? Source: Eur Respir J 2001; 18: Suppl. 33, 179s Year: 2001 Exhaled nitric oxide after lung transplantation: impact of the native lung Source: Eur Respir J 2003; 21: 429-432 Year: 2003 Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Source: Eur Respir J 2006; 28: 1236-1244 Year: 2006 Extended measurement of exhaled nitric oxide in patients after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 705s Year: 2005 Measurement of alveolar nitric oxide in patients with lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 The impact of lung cancer subtypes, smoking status and corticosteroid treatment on exhaled nitric oxide levels in patients with lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 The source of exhaled nitric oxide does not correlate with clinical markers in interstitial lung disease Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Time course of exhaled hydrogen peroxide (H2O2) and nitric oxide (eNO) during chemotherapy in patients with lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005 Diagnostic use of exhaled nitric oxide (eNO) after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 723s Year: 2006 Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 Exhaled nitric oxide in infants: a marker of inflammation? Source: Eur Respir Monogr 2010; 49: 56-70 Year: 2010 Bronchodilator response and previous lung function decline in relation with exhaled nitric oxide levels in asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients Source: Eur Respir J 2004; 24: Suppl. 48, 304s Year: 2004 The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma Source: Eur Respir J 2005; 25: 289-294 Year: 2005 Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC) Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006 Fractionated exhaled nitric oxide in COPD patients Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019